Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,557,865
+$164,794 QoQ
Shares Held
14,009
+0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#1,871
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOLDERNESS INVESTMENTS CO holds $26,485,557 across 10 Drug Manufacturers - General names. JNJ ranks #3 (13.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
23,463 | $5,904,229 | |
| 2 | MRK |
Merck & Co., Inc.
|
32,731 | $4,205,933 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
14,009 | $3,557,865 | |
| 4 | AMGN |
Amgen Inc
|
8,409 | $3,045,067 | |
| 5 | LLY |
ELI LILLY & Co
|
1,881 | $2,256,128 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
36,710 | $2,115,230 | |
| 7 | PFE |
Pfizer Inc
|
76,281 | $1,836,846 | |
| 8 | NVS |
Novartis AG
|
10,410 | $1,631,455 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,557,865 | 14,009 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,393,071 | 13,881 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,880,330 | 13,918 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,579,563 | 13,912 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,379,845 | 15,580 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,122,269 | 18,827 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,720,446 | 18,811 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $3,058,072 | 18,870 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,758,039 | 18,870 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,998,807 | 18,957 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,035,426 | 19,366 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,034,321 | 19,482 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $3,271,833 | 19,767 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $3,415,580 | 22,036 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,920,570 | 22,194 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,607,968 | 22,086 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,120,894 | 23,215 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,370,491 | 24,660 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,863,273 | 22,583 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $3,562,528 | 22,059 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,170,887 | 25,318 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $4,138,497 | 25,181 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $3,522,636 | 22,383 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $3,486,471 | 23,418 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $3,211,848 | 22,839 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,696,032 | 20,560 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||